GEMAYEL GEORGES

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GEMAYEL GEORGES's trades of Supernus Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-06
S Sale
31,826 +12.4%
419.81
US$487,309 		31,826 +12.4% 419.81 US$487,309
2026-03-06 2026-03-06
PrS Proposed sale
2,251
26.25
US$1,740,395 		2,251 26.25 US$1,740,395
2026-03-09 2026-03-05
S Sale
48,334 -12.4%
284.03
US$3,148,003 		48,334 -12.4% 284.03 US$3,148,003
2026-03-05 2026-03-05
PrS Proposed sale
10,000
53.71
US$537,117 		10,000 53.71 US$537,117
2024-11-12 2024-11-08
S Sale
10,787 -44.8%
36.30
US$391,568 		10,787 -44.8% 36.30 US$391,568
2024-11-08 2024-11-08
PrS Proposed sale
10,787
36.30
US$391,536 		10,787 36.30 US$391,536
2024-11-08 2024-11-07
S Sale
14,213 -51.6%
36.62
US$520,480 		14,213 -51.6% 36.62 US$520,480
2024-11-07 2024-11-07
PrS Proposed sale
14,213
36.62
US$520,511 		14,213 36.62 US$520,511
2024-09-17 2024-09-13
S Sale
10,000 -42.9%
31.33
US$313,300 		10,000 -42.9% 31.33 US$313,300
2024-09-17 2024-09-13
S Sale
3,886 -22.6%
31.33
US$121,748 		3,886 -22.6% 31.33 US$121,748
2024-09-13 2024-09-13
PrS Proposed sale
13,886
31.33
US$435,041 		13,886 31.33 US$435,041
2020-08-07 2020-08-05
PlS Planned sale
10,000 -41.5%
33.00
US$330,000 		10,000 -41.5% 33.00 US$330,000
2020-07-30 2020-07-29
PlS Planned sale
10,000 -41.5%
30.00
US$300,000 		10,000 -41.5% 30.00 US$300,000